MID-VOLUME · HOSP-HEAVY
posaconazole Side Effects
posaconazole (also sold as Noxafil) sits MID-VOLUME #270 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 44.9% mention hospitalization (6,890 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 15,332
- FAERS reports
FDA Adverse Event Reporting System extract for posaconazole. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
posaconazole: 44.9% mention hospitalization (6,890 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #270 of 524 by FAERS report count.
Mid-book FAERS page for posaconazole (Noxafil) (15,332 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
FEBRILE NEUTROPENIA leads 1,017 of 15,332 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (4,074 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (3,711 reports, 24.2%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 923 |
| SEPTIC SHOCK | 329 |
| PNEUMONIA | 252 |
| SEPSIS | 231 |
| FEBRILE NEUTROPENIA | 218 |
| PYREXIA | 207 |
| ACUTE MYELOID LEUKAEMIA | 204 |
| RESPIRATORY FAILURE | 196 |
| NEUTROPENIA | 187 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 167 |
| CONDITION AGGRAVATED | 130 |
| INFECTION | 130 |
| DISEASE PROGRESSION | 121 |
| DIARRHOEA | 110 |
| ACUTE KIDNEY INJURY | 109 |
| ASPERGILLUS INFECTION | 104 |
| THROMBOCYTOPENIA | 104 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (6,890, 44.9% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| FEBRILE NEUTROPENIA | 722 |
| PYREXIA | 589 |
| PNEUMONIA | 513 |
| DRUG INTERACTION | 396 |
| NEUTROPENIA | 365 |
| THROMBOCYTOPENIA | 303 |
| ACUTE KIDNEY INJURY | 293 |
| NAUSEA | 275 |
| SEPSIS | 269 |
| DIARRHOEA | 268 |
| SEPTIC SHOCK | 254 |
| CONDITION AGGRAVATED | 243 |
| PANCYTOPENIA | 216 |
| DYSPNOEA | 213 |
| VOMITING | 205 |
| ASTHENIA | 192 |
| RENAL FAILURE | 184 |
| FATIGUE | 182 |
How to read posaconazole FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 15,332 voluntary reports linked to posaconazole (Noxafil), 2004-2025. Death is listed on 3,711 (24.2%). Hospitalization appears on 6,890 (44.9%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 44.9% mention hospitalization (6,890 reports).
Read with posaconazole
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 15,513 FAERS cases (Δ 181 heavier vs posaconazole); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 15,113 FAERS cases (Δ 219 lighter vs posaconazole); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 15,616 FAERS cases (Δ 284 heavier vs posaconazole); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 14,997 FAERS cases (Δ 335 lighter vs posaconazole); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 37.9 pp vs posaconazole's DEATH-HEAVY): CASELOAD · HOSP-MID.
posaconazole stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.